NATCO PHARMA
Back to Income Statement
|
NATCO PHARMA Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹2,194 Cr | ₹1,751 Cr | ₹912 Cr | ₹264 Cr | ₹604 Cr |
What is the latest Operating Profit of NATCO PHARMA ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹2,194 Cr |
| Mar2024 | ₹1,751 Cr |
| Mar2023 | ₹912 Cr |
| Mar2022 | ₹264 Cr |
| Mar2021 | ₹604 Cr |
How is Operating Profit of NATCO PHARMA Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,194 Cr | 25.26 | |
| Mar2024 | ₹1,751 Cr | 92.10 | |
| Mar2023 | ₹912 Cr | 246.00 | |
| Mar2022 | ₹264 Cr | -56.36 | |
| Mar2021 | ₹604 Cr | - | |
Compare Operating Profit of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹16,742.3 Cr | -3.2% | 5.7% | -4.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,179.0 Cr | -0.4% | 4.3% | 13.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,095.0 Cr | 0.9% | 8.9% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,530.0 Cr | 0.7% | 13% | 46.5% | Stock Analytics | |
| CIPLA | ₹114,318.0 Cr | -1% | -0% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,742.1 Cr | -3.3% | -8.4% | -4.3% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -3.2% |
5.7% |
-4.8% |
| SENSEX | -0.6% |
-0.1% |
-6.7% |
You may also like the below Video Courses